Ignite Creation Date:
2025-12-24 @ 6:52 PM
Ignite Modification Date:
2026-01-02 @ 10:07 AM
Study NCT ID:
NCT00527657
Status:
COMPLETED
Last Update Posted:
2018-11-14
First Post:
2007-09-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma Patients
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-02-09
Start Date Type:
None
Primary Completion Date:
2012-02-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-02-02
Completion Date Type:
ACTUAL
First Submit Date:
2007-09-10
First Submit QC Date:
None
Study First Post Date:
2007-09-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-11-12
Last Update Post Date:
2018-11-14
Last Update Post Date Type:
ACTUAL